LeMaitre Vascular, Inc. (LMAT)

LeMaitre Vascular Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	30.11	20.64	26.91	21.22	17.93
Depreciation & Amortization	9.52	9.43	11.07	8.4	5.42
Share-Based Compensation	5.32	4.17	3.48	3.02	2.64
Other Operating Activities	-8.19	-8.86	-6.35	2.16	-11.81
Operating Cash Flow	36.75	25.38	35.1	34.8	14.18
Operating Cash Flow Growth	44.81%	-27.70%	0.87%	145.43%	-27.31%
Capital Expenditures	-7.27	-2.37	-4.88	-0.96	-3.76
Acquisitions	-0.9	0	0	-72.63	-21.24
Change in Investments	-16.55	-8	-56.19	20.7	0.9
Investing Cash Flow	-24.72	-10.37	-61.08	-52.89	-24.1
Dividends Paid	-12.45	-10.99	-9.34	-7.7	-6.74
Share Issuance / Repurchase	5.32	2.82	62.44	5.4	4.17
Debt Issued / Paid	0	0	-39	39	0
Other Financing Activities	-	-1.07	-0.4	-4.55	-2.06
Financing Cash Flow	-7.13	-9.23	13.7	32.16	-4.62
Exchange Rate Effect	0.23	-0.49	-0.64	0.91	0.01
Net Cash Flow	5.14	5.28	-12.91	14.98	-14.53
Free Cash Flow	29.49	23.01	30.22	33.84	10.42
Free Cash Flow Growth	28.16%	-23.87%	-10.70%	224.83%	-36.68%
Free Cash Flow Margin	15.24%	14.23%	19.57%	26.16%	8.89%
Free Cash Flow Per Share	1.33	1.05	1.43	1.67	0.53

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).